688319 欧林生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.9642.4352.2541.9523.079
总资产报酬率 ROA (%)1.3451.1621.2141.1361.975
投入资产回报率 ROIC (%)1.9781.6801.6931.6022.763

边际利润分析
销售毛利率 (%)91.84192.95994.44693.55092.865
营业利润率 (%)20.5274.3823.6190.6257.601
息税前利润/营业总收入 (%)23.2166.5865.4884.0918.212
净利润/营业总收入 (%)17.2353.1102.6702.3064.854

收益指标分析
经营活动净收益/利润总额(%)65.779141.22984.56733.73167.609
价值变动净收益/利润总额(%)0.3861.5613.8366.6718.478
营业外收支净额/利润总额(%)0.0923.2484.45480.1594.656

偿债能力分析
流动比率 (X)1.3551.3521.5251.9551.782
速动比率 (X)1.2651.2671.3811.8041.632
资产负债率 (%)53.90055.31648.34142.28239.694
带息债务/全部投入资本 (%)29.02829.24426.11518.65811.303
股东权益/带息债务 (%)230.772227.286274.486422.883757.413
股东权益/负债合计 (%)85.50080.751105.854134.475150.186
利息保障倍数 (X)8.6943.2023.2274.33534.304

营运能力分析
应收账款周转天数 (天)388.432312.370323.304356.438272.293
存货周转天数 (天)450.323537.553868.416847.387705.108